What is DexCom's expected EPS for Q2 2026?

Analysts expect DexCom (DXCM) to report consensus EPS of approximately $0.61 for Q2 2026. Estimates range from $0.57 to $0.66.

What revenue do analysts expect for DexCom in Q2 2026?

The consensus revenue forecast for DexCom (DXCM) in Q2 2026 is approximately $1.29B. Forecasts range from $1.28B to $1.3B.

How many analysts cover DexCom?

14 analysts contribute to the DexCom (DXCM) Q2 2026 consensus estimate.

Has DexCom beaten earnings estimates recently?

DexCom beat analyst EPS estimates in 1 of the last 1 quarter. DexCom beat revenue estimates in 1 of 1. In the most recent quarter (Q1 2026), DexCom EPS beat by 20.3% and revenue beat by 1.5%.

When does DexCom report Q2 2026 earnings?

DexCom (DXCM) is expected to report Q2 2026 earnings on July 30, 2026 after market close.

DXCM Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$0.61

Consensus revenue · Q2 2026

$1.3B

Analysts

Expected report

Jul 30, 2026

After close

Upcoming earnings

Locks in 7 days 9 hours · AMC: Locks at 4:00 PM ET on report day

Revenue$1.3B$1.3B – $1.3B

EPS$0.61$0.57 – $0.66

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 14 analysts.

Metric	Low	Consensus	High
Revenue	$1.3B	$1.3B	$1.3B
EPS	$0.57	$0.61	$0.66
EBITDA	$539.5M	$543.7M	$558.6M
EBIT	$461M	$464.5M	$477.3M
Net income	$227.9M	$239.7M	$251.5M

Revenue$1.3B
EPS$0.61
EBITDA$543.7M
EBIT$464.5M
Net income$239.7M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$1.2B	$1.2B	+1.5%	$0.56	$0.47	+20.3%

Q1 2026+1.5%+20.3%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for DexCom (DXCM) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 2 analysts.

Low: $64.00
Consensus: $84.09
Median: $86.00
High: $95.00
Current: $71.43
Upside: +17.7%

Upside calculated vs most recent trading price of $71.43.

Analyst ratings

Consensus: Buy — based on 52 analyst ratings.

Strong Buy 1Buy 41Hold 8Sell 2

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 16, 2026	Truist Securities	maintain	Buy	Buy
Jul 15, 2026	Mizuho	maintain	Outperform	Outperform
Jun 23, 2026	Deutsche Bank	maintain	Buy	Buy
Jun 15, 2026	Piper Sandler	maintain	Overweight	Overweight
Jun 10, 2026	TD Cowen	maintain	Buy	Buy
Jun 9, 2026	Mizuho	maintain	Outperform	Outperform
Jun 5, 2026	Stifel	maintain	Buy	Buy
May 28, 2026	Citigroup	maintain	Buy	Buy
May 18, 2026	Canaccord Genuity	maintain	Buy	Buy
May 18, 2026	Barclays	maintain	Underweight	Underweight

Jul 16, 2026Truist SecuritiesBuy
Jul 15, 2026MizuhoOutperform
Jun 23, 2026Deutsche BankBuy
Jun 15, 2026Piper SandlerOverweight
Jun 10, 2026TD CowenBuy
Jun 9, 2026MizuhoOutperform
Jun 5, 2026StifelBuy
May 28, 2026CitigroupBuy
May 18, 2026Canaccord GenuityBuy
May 18, 2026BarclaysUnderweight

Frequently asked questions

DexCom (DXCM) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

DXCM Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation